GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY

被引：0
|
作者：
Sever, M. Jensterle [1 ,2 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
230
引用
收藏
页码：A6 / A6
页数：1
相关论文
共 50 条
  • [11] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570
  • [12] Obesity and GLP-1 RAs
    Bright, Tamis
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 1 - 2
  • [13] GLP-1 Agonists for Obesity
    Mozaffarian, Dariush
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [14] GLP-1 Agonists for Obesity
    Moran, Alyssa J.
    Roberto, Christina A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [15] Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity
    Maselli, Daniel B.
    Camilleri, Michael
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 171 - 192
  • [16] GLP-1 RECEPTOR AGONIST TREATMENT IN SCHIZOPHRENIA PATIENTS WITH OBESITY
    Ishoy, Pelle L.
    Knop, Filip K.
    Broberg, Brian V.
    Bak, Nikolaj
    Andersen, Ulrik B.
    Jorgensen, Niklas R.
    Fagerlund, Birgitte
    Holst, Jens J.
    Glenthoj, Birte Y.
    Ebdrup, Bjorn
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S167 - S167
  • [17] Patient initiation and maintenance of GLP-1 RAs for treatment of obesity
    Patel, Dhiren
    Smith, April
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (10) : 1193 - 1204
  • [18] Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity
    Waldrop, Stephanie W.
    Johnson, Veronica R.
    Stanford, Fatima Cody
    NATURE MEDICINE, 2024, 30 (1) : 22 - 25
  • [19] Emerging role of GLP-1 receptor agonists in the treatment of obesity
    Neff, Lisa M.
    Kushner, Robert F.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 263 - 273
  • [20] Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity
    Stephanie W. Waldrop
    Veronica R. Johnson
    Fatima Cody Stanford
    Nature Medicine, 2024, 30 : 22 - 25
12345